Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
TelomEye Pharmaceuticals
company
About
TelomEye Pharmaceuticals provides treatments to prevent and improve age-related ophthalmologic disorders.
- 1 - 10
Highlights
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $1M
- Industries
- Health Care,Health Diagnostics
- Founded date
- Jan 1, 2021
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$1M
TelomEye Pharmaceuticals has raised a total of
$1M
in funding over 2 rounds. Their latest funding was raised on
Nov 17, 2022 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 17, 2022 | Seed | $1M | 1 |
Re-Pie Asset Management
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
TelomEye Pharmaceuticals is funded by 1 investors.
Re-Pie Asset Management
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Re-Pie Asset Management
|
Yes | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
